Ipamorelin: Mechanism of Action

Molecular class and structure

Ipamorelin is a pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 (a C-terminal amide). It belongs to the growth-hormone-releasing-peptide (GHRP) family of small-molecule secretagogues but is structurally distinct from earlier members of that family.

The molecular formula is C38H49N9O5 with a monoisotopic molar mass of approximately 711.9 g/mol (CAS 170851-70-4). The inclusion of the non-natural residues alpha-aminoisobutyric acid (Aib) and D-2-naphthylalanine (D-2-Nal), together with the C-terminal amide, gives the molecule resistance to peptidase degradation and contributes to its receptor selectivity.

Receptor target and signaling

Ipamorelin is an agonist at the growth-hormone secretagogue receptor (GHSR-1a), the endogenous receptor for ghrelin. GHSR-1a is a Gq/11-coupled G-protein-coupled receptor; agonist binding activates phospholipase C, generating inositol trisphosphate and diacylglycerol, mobilizing intracellular calcium and driving growth-hormone release from pituitary somatotrophs.

Because this is a different receptor and a different intracellular pathway (Gq/PLC/calcium) from the GHRH receptor (Gs/cAMP/PKA), the ghrelin-receptor axis is mechanistically complementary to GHRH-analog signaling — a distinction that underlies much of the co-study literature.

Selectivity vs GHRP-2 and GHRP-6

The defining feature of ipamorelin in the research literature is its selectivity. Earlier GHRPs such as GHRP-2 and GHRP-6 are potent GHSR agonists but are reported to also stimulate release of adrenocorticotropic hormone (ACTH), cortisol, and — in the case of GHRP-6 — prolactin, reflecting off-target activity beyond the somatotroph axis.

Ipamorelin is characterized as producing a comparatively clean GHSR-mediated signal with minimal reported effect on ACTH, cortisol, or prolactin at comparable exposures in model systems. This selectivity is why ipamorelin is frequently chosen as the reference GHSR agonist when researchers want to isolate ghrelin-receptor signaling from confounding endocrine effects.

• GHRP-6: GHSR agonist; reported ACTH, cortisol and prolactin stimulation.
• GHRP-2: GHSR agonist; reported ACTH/cortisol activity.
• Ipamorelin: GHSR agonist with minimal reported ACTH/cortisol/prolactin effect — the selective reference.

Why it is paired with GHRH analogs

Ipamorelin's GHSR agonism and a GHRH analog's GHRHR agonism act through separate receptor systems that the literature examines together. The two pathways are studied as complementary inputs to the same somatotroph cell population, which is why a selective GHSR agonist and a GHRH analog form a common experimental pair. The mechanistic rationale is detailed in the comparison reference.

Laboratory handling and verification

Ipamorelin is supplied as a lyophilized powder and handled under standard peptide research practice — reconstitution with a suitable sterile diluent, aliquoting, and cold storage to limit freeze-thaw exposure.

Each Kairo Labs lot is verified to the lot with a Certificate of Analysis reporting identity and purity by mass spectrometry and HPLC, so the pentapeptide's identity and grade are confirmed before experimental use.